Rachel E Patzer1, Laura C Plantinga2, Sudeshna Paul3, Jennifer Gander4, Jenna Krisher5, Leighann Sauls5, Eric M Gibney6, Laura Mulloy7, Stephen O Pastan8. 1. Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia2Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia3Emory Transplant Center, Atlanta, Georgia. 2. Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia4Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. 3. Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia. 4. Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia. 5. Southeastern Kidney Council Inc of End Stage Renal Disease Network 6, Raleigh, North Carolina. 6. Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, Georgia. 7. Division of Nephrology, Department of Medicine, Georgia Regents University, Augusta. 8. Emory Transplant Center, Atlanta, Georgia4Renal Division, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Abstract
IMPORTANCE: Dialysis facilities in the United States are required to educate patients with end-stage renal disease about all treatment options, including kidney transplantation. Patients receiving dialysis typically require a referral for kidney transplant evaluation at a transplant center from a dialysis facility to start the transplantation process, but the proportion of patients referred for transplantation is unknown. OBJECTIVE: To describe variation in dialysis facility-level referral for kidney transplant evaluation and factors associated with referral among patients initiating dialysis in Georgia, the US state with the lowest kidney transplantation rates. DESIGN, SETTING, AND PARTICIPANTS: Examination of United States Renal Data System data from a cohort of 15,279 incident, adult (18-69 years) patients with end-stage renal disease from 308 Georgia dialysis facilities from January 2005 to September 2011, followed up through September 2012, linked to kidney transplant referral data collected from adult transplant centers in Georgia in the same period. MAIN OUTCOMES AND MEASURES: Referral for kidney transplant evaluation within 1 year of starting dialysis at any of the 3 Georgia transplant centers was the primary outcome; placement on the deceased donor waiting list was also examined. RESULTS: The median within-facility percentage of patients referred within 1 year of starting dialysis was 24.4% (interquartile range, 16.7%-33.3%) and varied from 0% to 75.0%. Facilities in the lowest tertile of referral (<19.2%) were more likely to treat patients living in high-poverty neighborhoods (absolute difference, 21.8% [95% CI, 14.1%-29.4%]), had a higher patient to social worker ratio (difference, 22.5 [95% CI, 9.7-35.2]), and were more likely nonprofit (difference, 17.6% [95% CI, 7.7%-27.4%]) compared with facilities in the highest tertile of referral (>31.3%). In multivariable, multilevel analyses, factors associated with lower referral for transplantation, such as older age, white race, and nonprofit facility status, were not always consistent with the factors associated with lower waitlisting. CONCLUSIONS AND RELEVANCE: In Georgia overall, a limited proportion of patients treated with dialysis were referred for kidney transplant evaluation between 2005 and 2011, but there was substantial variability in referral among facilities. Variables associated with referral were not always associated with waitlisting, suggesting that different factors may account for disparities in referral.
IMPORTANCE: Dialysis facilities in the United States are required to educate patients with end-stage renal disease about all treatment options, including kidney transplantation. Patients receiving dialysis typically require a referral for kidney transplant evaluation at a transplant center from a dialysis facility to start the transplantation process, but the proportion of patients referred for transplantation is unknown. OBJECTIVE: To describe variation in dialysis facility-level referral for kidney transplant evaluation and factors associated with referral among patients initiating dialysis in Georgia, the US state with the lowest kidney transplantation rates. DESIGN, SETTING, AND PARTICIPANTS: Examination of United States Renal Data System data from a cohort of 15,279 incident, adult (18-69 years) patients with end-stage renal disease from 308 Georgia dialysis facilities from January 2005 to September 2011, followed up through September 2012, linked to kidney transplant referral data collected from adult transplant centers in Georgia in the same period. MAIN OUTCOMES AND MEASURES: Referral for kidney transplant evaluation within 1 year of starting dialysis at any of the 3 Georgia transplant centers was the primary outcome; placement on the deceased donor waiting list was also examined. RESULTS: The median within-facility percentage of patients referred within 1 year of starting dialysis was 24.4% (interquartile range, 16.7%-33.3%) and varied from 0% to 75.0%. Facilities in the lowest tertile of referral (<19.2%) were more likely to treat patients living in high-poverty neighborhoods (absolute difference, 21.8% [95% CI, 14.1%-29.4%]), had a higher patient to social worker ratio (difference, 22.5 [95% CI, 9.7-35.2]), and were more likely nonprofit (difference, 17.6% [95% CI, 7.7%-27.4%]) compared with facilities in the highest tertile of referral (>31.3%). In multivariable, multilevel analyses, factors associated with lower referral for transplantation, such as older age, white race, and nonprofit facility status, were not always consistent with the factors associated with lower waitlisting. CONCLUSIONS AND RELEVANCE: In Georgia overall, a limited proportion of patients treated with dialysis were referred for kidney transplant evaluation between 2005 and 2011, but there was substantial variability in referral among facilities. Variables associated with referral were not always associated with waitlisting, suggesting that different factors may account for disparities in referral.
Authors: Mireille N Kianda; Karl M Wissing; Nulifer E Broeders; Anne Lemy; Lidia Ghisdal; Anh D Hoang; Dimitri Mikhalski; Vincent Donckier; Pierre Vereerstraeten; Daniel Abramowicz Journal: Clin Transplant Date: 2010-08-16 Impact factor: 2.863
Authors: John Z Ayanian; Paul D Cleary; Joseph H Keogh; Susan J Noonan; Jo Ann David-Kasdan; Arnold M Epstein Journal: Am J Kidney Dis Date: 2004-02 Impact factor: 8.860
Authors: Rachel E Patzer; Sandra Amaral; Haimanot Wasse; Nataliya Volkova; David Kleinbaum; William M McClellan Journal: J Am Soc Nephrol Date: 2009-04-01 Impact factor: 10.121
Authors: David D Aufhauser; Allison W Peng; Douglas R Murken; Seth J Concors; Peter L Abt; Deirdre Sawinski; Roy D Bloom; Peter P Reese; Matthew H Levine Journal: Clin Transplant Date: 2018-06-25 Impact factor: 2.863
Authors: Rachel E Patzer; Sudeshna Paul; Laura Plantinga; Jennifer Gander; Leighann Sauls; Jenna Krisher; Laura L Mulloy; Eric M Gibney; Teri Browne; Carlos F Zayas; William M McClellan; Kimberly Jacob Arriola; Stephen O Pastan Journal: J Am Soc Nephrol Date: 2016-10-13 Impact factor: 10.121
Authors: Christine E Haugen; Nadia M Chu; Hao Ying; Fatima Warsame; Courtenay M Holscher; Niraj M Desai; Miranda R Jones; Silas P Norman; Daniel C Brennan; Jacqueline Garonzik-Wang; Jeremy D Walston; Adam W Bingaman; Dorry L Segev; Mara McAdams-DeMarco Journal: Clin J Am Soc Nephrol Date: 2019-03-19 Impact factor: 8.237
Authors: Meera N Harhay; Michael O Harhay; Karthik Ranganna; Suzanne M Boyle; Lissa Levin Mizrahi; Stephen Guy; Gregory E Malat; Gary Xiao; David J Reich; Rachel E Patzer Journal: Clin Transplant Date: 2018-09-15 Impact factor: 2.863
Authors: Sarah Streeter Hutcheson; Victoria Phillips; Rachel Patzer; Andrew Smith; J David Vega; Alanna A Morris Journal: Clin Transplant Date: 2018-07-11 Impact factor: 2.863
Authors: Sudeshna Paul; Laura C Plantinga; Stephen O Pastan; Jennifer C Gander; Sumit Mohan; Rachel E Patzer Journal: Clin J Am Soc Nephrol Date: 2018-01-25 Impact factor: 8.237